Medical Cannabis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
HGV | A | Hygrovest Limited | 0.00 | |
LGP | A | Little Green Pharma Ltd | 0.00 | |
IRX | B | InhaleRx Limited | -10.26 | |
AGH | B | Althea Group Holdings Limited | 0.00 | |
EXL | C | Elixinol Global Limited | 0.00 | |
VIT | C | Vitura Health Limited | 0.00 | |
EPN | C | Epsilon Healthcare Limited | 0.00 | |
CAN | F | Cann Group Ltd | 0.00 | |
BOD | F | Bod Australia Limited | 0.00 | |
ME1 | F | Melodiol Global Health Ltd | 0.00 |
Related Industries: Drug Manufacturers - Specialty & Generic Drug Manufacturers—Specialty & Generic Farm & Heavy Construction Machinery Household & Personal Products Medical Devices
- Medical Cannabis
Medical cannabis, or medical marijuana, is cannabis and cannabinoids that are recommended by doctors for their patients. The use of cannabis as medicine has not been rigorously tested due to production restrictions and other governmental regulations. Limited evidence suggests that cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms.Short-term use increases the risk of minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years in many cultures. A number of medical organizations have requested removal of cannabis from the list of Schedule I controlled substances, followed by regulatory and scientific review. Others oppose its legalization, such as the American Academy of Pediatrics.Medical cannabis can be administered through a variety of methods, including capsules, lozenges, tinctures, dermal patches, oral or dermal sprays, cannabis edibles, and vaporizing or smoking dried buds. Synthetic cannabinoids are available for prescription use in some countries, such as dronabinol and nabilone. Countries that allow the medical use of whole-plant cannabis include Australia, Canada, Chile, Colombia, Germany, Greece, Israel, Italy, the Netherlands, Peru, Poland, Portugal, and Uruguay. In the United States, 33 states and the District of Columbia have legalized cannabis for medical purposes, beginning with the passage of California's Proposition 215 in 1996. Although cannabis remains prohibited for any use at the federal level, the Rohrabacher–Farr amendment was enacted in December 2014, limiting the ability of federal law to be enforced in states where medical cannabis has been legalized.
Recent Comments
- TRTCryptoCraig on Bad Quotes for 28 May...
- TraderMike on Bad Quotes for 28 May...
- TraderMike on Market Recap for Friday, May 31, 2024
- PleasantTurtle699 on Market Recap for Friday, May 31, 2024
- TraderMike on Market Recap for Friday, May 31, 2024
From the Blog
Featured Articles